Email Updates

You are here

Home

16 JUNE 2023 VOLUME 25 ISSUE 24

Media Coverage

  • New Case of HIV Cure: Joined Forces of Haploidentical Stem Cells and HLA-Mismatched Cord Blood

    Recently, Hsu et al. reported the remission and possible cure of HIV-1 infection in the context of an allogeneic hematopoietic stem cell transplant for the treatment of acute myeloid leukemia (AML). This is the fourth case of a potential cure for HIV infection ever, the first in a woman, the first in a person of mixed race, and the first in which a CCR5Δ32/Δ32 haplo-cord transplant was used.

    June 16, 2023
    Cure
    Nature

  • Uganda’s Anti-Gay Law Will Hurt All Ugandans

    On May 26, Ugandan President Yoweri Museveni signed the nation’s Anti-Homosexuality Act, also known as the AHA. Uganda is far from the only nation to criminalize homosexuality — at least 62 other countries, most of them in Africa and the Middle East, also have anti-gay laws on the books. But Uganda’s regulation cracking down on LGBTQ existence is especially draconian. It outlaws same-sex sexual activity but also punishes others who merely tolerate the existence of queer people. According to the law, a person can be punished for even leasing property to a gay person.

    June 16, 2023
    General
    Globe Echo

  • HIV-Positive Women With Health Insurance Are More Likely to Get Hepatitis C Treatment

    Women living with HIV who have health insurance are much more likely to start direct-acting antiviral therapy for hepatitis C than those who do not have insurance, but those covered by Medicaid are less likely to initiate treatment than those with private insurance, according to study findings published in Clinical Infectious Diseases.

    June 15, 2023
    General
    POZ Magazine

  • Patients with HIV in US saw rise of rare, deadly bacterial illness last year: CDC

    Patients with HIV in the United States saw an increase in rare, deadly meningococcal infections last year, new preliminary data shows. Nearly 10 percent of all meningococcal disease cases in 2022 were among people with HIV, according to a report published Thursday afternoon by the Centers for Disease Control and Prevention.

    June 15, 2023
    General
    ABC News

  • Biden Administration Finalizes Deal Preserving Preventive Healthcare Coverage During Legal Challenge

    The Biden administration on Monday finalized a deal to preserve the federal mandate requiring US health insurers to cover preventive care like cancer screenings and HIV-preventing medication at no extra cost to patients while a legal challenge continues. The agreement, first disclosed on Friday and now finalized in a filing in the New Orleans-based 5th US Circuit Court of Appeals, leaves the mandate in place nationwide while the administration appeals a court order striking it down.

    June 13, 2023
    Reuters

  • More Evidence That Long COVID Is More Common in People With HIV

    People with HIV are more likely to experience ‘long COVID’ symptoms and to experience serious cardiovascular and metabolic disorders and cancers after being diagnosed with COVID-19, a large US study has found. Two US researchers involved in long COVID research say there is an urgent need to understand why people with HIV are more vulnerable to long COVID and to include them in clinical trials of potential long COVID treatments.

    June 13, 2023
    General
    aidsmap

  • Investigators Advance PrEPVacc Trial To Evaluate HIV Vaccine Efficacy

    Investigators are moving into the post-recruitment phase of the PrEPVacc trial—a non-licensed study based in Africa that will provide insights on 2 investigational combination HIV vaccine regimens and a novel oral pre-exposure prophylaxis (PrEP) to prevent HIV vaccine—according to a recent press release.

    June 13, 2023
    PrEP
    Pharmacy Times

  • Stigma Hindering HIV Treatment Advances In Malaysia: Expert

    The advancement of HIV treatment is being stifled by persistent stigma and discrimination against key populations and people living with HIV (PLHIV) in the country, said infectious disease expert Prof Dr Christopher Lee. Despite effective therapies becoming more readily available, societal attitudes are deterring patients from seeking the care they need, thereby impeding the nation’s efforts to combat and eliminate the HIV/AIDS epidemic by 2030.

    June 12, 2023
    Treatment
    CodeBlue

  • HIV Care for Migrant Women in South Africa: The Gaps and 5 Steps Towards Offering Better Services

    Around 8.45 million people in South Africa live with HIV – an estimated 13.9 percent of the population. Of South African women aged 15-49, approximately 24 percent are HIV positive. The roll-out of services to prevent mother-to-child transmission of HIV has been notably successful in reducing the rate of transmission.

    June 12, 2023
    General
    The Conversation

  • Power Up To Investigate PrEP

    Black African American cisgender heterosexual women are disproportionately affected by HIV, but prescriptions for pre-exposure prophylaxis (PrEP) do not reflect this situation. Few studies of PrEP have been specifically designed to investigate women; thus, the PrEP Optimization among Women to Enhance Retention and Uptake (POWER Up) study has been initiated to assess implementation strategies to improve PrEP uptake and persistence in Black women in the Midwest and South USA.

    June 12, 2023
    PrEP
    Nature

  • Overcoming Misinformation Starts With 1 Person at a Time

    The federal government’s public health emergency declaration for COVID-19 ended on May 11, but experts said the impact of vaccine misinformation and disinformation lingers. In fact, it is also affecting other vaccines. “The whole COVID vaccine experience has energized the anti-vaccine movement now, and the public health community is very wary of this,” said William Schaffner, MD, a professor of preventive medicine in the Department of Health Policy at Vanderbilt University School of Medicine, in Nashville, Tenn.

    June 12, 2023
    General
    Infectious Disease Special Edition

  • Antiretroviral Treatment Efficiently Suppresses Penile HIV Replication

    Of the 38 million people worldwide living with HIV, approximately 700,000 are newly infected men, primarily via sexual transmission. Sexually transmitted HIV infections in exclusively heterosexual men are acquired through the penis. In addition, semen which is produced in the male genital tract (MGT) has been recognized as the primary vector for vaginal and rectal HIV transmission. Notably, the risk of sexual HIV transmission increases with the presence of a concurrent sexually transmitted infection.

    June 12, 2023
    Treatment
    News Medical

  • Effects of Ugandan Anti-LGBT Law: Emptying HIV Clinics

    In the Ugandan capital of Kampala, the usually buzzing HIV/AIDS treatment center is almost empty days after parliament enacted a controversial anti-gay law. According to staff, the usual daily influx of approximately 50 patients has dried up, antiretroviral drugs pile up unused. A resident medical officer at a US-funded clinic, warned that new waves of HIV infections were forming as vulnerable people stayed away from treatment centers, afraid of being identified and arrested under the new laws.

    June 12, 2023
    General
    Africa News

  • Scientists Hopeful After Making HIV Drug Breakthrough in Hunt for Dementia Cure

    Dementia comes in different forms but a common feature is the build-up in the brain of clusters of abnormal proteins which leads to the eventual death of brain cells. One of the ways our body rids itself of these toxic proteins is through autophagy, or ‘self-eating’, where cells eat the toxic material, break it down and discard it.

    June 11, 2023
    Treatment
    Mirror

Published Research

Announcements